Company intelligence / Profile preview

Salignostics

Ownership: Private
Development stage: Commercial

Overview

Salignostics has developed the world’s first commercialized rapid saliva-based pregnancy test (“Salistick”), recognized by TIME magazine as one of the best inventions of 2023. The company also offers a CE-pending COVID‑19 antigen self-test (“SaliCov”) and has a proprietary platform enabling further expansion into infectious disease and health condition diagnostics using non-invasive saliva samples. Their products are designed to be user-friendly and do not require professional assistance or laboratory equipment. The company was spun out from Hebrew University of Jerusalem in 2016 and has raised $8M in Series A funding.

Therapeutic areas: Infectious DiseasesWomen's Health
Modalities: Device (diagnostic device)Lateral flow immunoassayRapid diagnostic test (RDT)
Industry: Protein Biomarker Diagnostics

Drug pipeline

1 asset

Salistick

Commercial

Indications: Pregnancy detection

Partnerships

Boots UK via Abingdon Health partnership for retail launch of Salistick pregnancy self-test in the UK market.

Beyond the preview

Go deeper on Salignostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salignostics.

Explore the full profile